Stocks and Investing Stocks and Investing
Thu, November 30, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (VSCO) at Hold and Held Target at $21 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Simeon Siegel Maintained (VSCO) at Buy with Increased Target to $29 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Nathan Jones Initiated (vlto) at Strong Buy and Held Target at $82 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (ZLAB) at Buy with Increased Target to $66 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Vafi Reiterated (ZUO) at Strong Buy and Held Target at $16 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Joshua Reilly Reiterated (ZUO) at Strong Buy and Held Target at $15 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Jeremy Metz Maintained (WEC) at Hold with Increased Target to $93 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Seth Basham Maintained (WOOF) at Buy with Decreased Target to $3.5 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Kate McShane Maintained (WOOF) at Strong Buy with Decreased Target to $5 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Alexander Blostein Maintained (BLK) at Strong Buy with Increased Target to $793 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (BIVI) at Buy with Decreased Target to $50 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Austin Wurschmidt Maintained (AVB) at Buy with Decreased Target to $200 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Michael Lewis Reiterated (AVB) at Strong Buy and Held Target at $202 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Steve Sakwa Maintained (AVB) at Buy with Increased Target to $188 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Sandeep Deshpande Maintained (ASML) at Buy with Increased Target to $878 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Stephen Scouten Maintained (AMTB) at Buy with Increased Target to $25 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Abhishek Sinha Initiated (AMPS) at Buy and Held Target at $10 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
A.J. Rice Initiated (AMN) at Hold and Held Target at $73 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Jiong Shao Downgraded (BILI) to Sell and Decreased Target to $10 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Lincoln Kong Maintained (BILI) at Hold with Decreased Target to $16 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Fawne Jiang Maintained (BILI) at Strong Buy with Decreased Target to $21 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
David Grossman Reiterated (ADP) at Hold and Held Target at $250 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Jeremy Metz Maintained (AEE) at Buy with Decreased Target to $89 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Duksan Jang Initiated (AEIS) at Hold and Held Target at $105 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Alexander Blostein Maintained (BAM) at Strong Buy with Decreased Target to $41 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Ketan Mamtora Maintained (AZEK) at Buy with Increased Target to $39 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Bill Carcache Upgraded (ALLY) to Buy and Held Target at $39 on, Nov 30th, 2023
[ 12:00 AM ] - WOPRAI
Floris Van Dijkum Downgraded (AKR) to Hold and Held Target at $16 on, Nov 30th, 2023
Wed, November 29, 2023
[ 12:00 AM ] - WOPRAI
Mitch Germain Initiated (ALEX) at Buy on, Nov 29th, 2023
[ 12:00 AM ] - WOPRAI
Julian Harrison Initiated (AKBA) at Strong Buy and Held Target at $4 on, Nov 29th, 2023

Julian Harrison Initiated (AKBA) at Strong Buy and Held Target at $4 on, Nov 29th, 2023


Published on 2024-10-28 07:47:02 - WOPRAI, Julian Harrison
  Print publication without navigation


Julian Harrison of BTIG, Initiated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy and Held Target at $4 on, Nov 29th, 2023.

Julian has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Julian's Rating of Hold.



This is the rating of the analyst that currently disagrees with Julian

  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5 on, Friday, November 17th, 2023
Contributing Sources